Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03326193
What this trial is testing

Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Who this might be right for
Ovarian Neoplasms
Tesaro, Inc. 105
Large-scale testing (Phase 3)Looking for participantsNCT05230758
What this trial is testing

Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour

Who this might be right for
Medulloblastoma, ChildhoodCognitive Impairment
Donald Mabbott 140
Testing effectiveness (Phase 2)Study completedNCT00436501
What this trial is testing

VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerMalignant Tumor of PeritoneumRecurrent Ovarian Epithelial Cancer
National Cancer Institute (NCI) 58
Large-scale testing (Phase 3)UnknownNCT05104281
What this trial is testing

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Qingdao Central Hospital 60
Not applicableStudy completedNCT05946928
What this trial is testing

EMERGENCE AGITATION After Premedication IN PAEDIATRIC MAGNETIC RESONANCE IMAGING: A RETROSPECTIVE COHORT STUDY

Who this might be right for
Autism Spectrum DisorderPremedicationBrain Neoplasms+2 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Not applicableNot Yet RecruitingNCT02990936
What this trial is testing

Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy

Who this might be right for
Head and Neck Squamous Cell CarcinomaTumor Growth
Centre Hospitalier Universitaire UCLouvain Namur 120
Testing effectiveness (Phase 2)UnknownNCT04664244
What this trial is testing

Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma

Who this might be right for
Recurrent Cervical CarcinomaRadiotherapyEpidermal Growth Factor Receptor+4 more
Lei Li 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT06449209
What this trial is testing

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

Who this might be right for
Extensive-stage Small-cell Lung CancerSmall-cell Lung Cancer
BioNTech SE 110
Testing effectiveness (Phase 2)Study completedNCT01250119
What this trial is testing

Assess the Incidence of EGFR Mutation in Patients With Newly Diagnosed Locally Advanced or Metastatic Non-Small Cell Lung Cancer in the UK, And of Tarceva (Erlotinib) as First-Line Therapy in EGFR Mutation Positive Patients.

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 688
Testing effectiveness (Phase 2)Ended earlyNCT01185509
What this trial is testing

Trastuzumab and Vinorelbine in Advanced Breast Cancer

Who this might be right for
Breast CancerMetastatic Breast Cancer
Dana-Farber Cancer Institute 31
Not applicableAvailableNCT07601399
What this trial is testing

An EAP Treatment Protocol of Zipalertinib

Who this might be right for
Non-Small Cell Lung Cancer
Taiho Oncology, Inc.
Testing effectiveness (Phase 2)Study completedNCT01153984
What this trial is testing

Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations

Who this might be right for
Carcinoma，Non-Small-Cell Lung
Hoffmann-La Roche 23
Not applicableStudy completedNCT07375407
What this trial is testing

Aerobic Exercise vs Physiological Ischemic Training in Stage 2 Hypertension

Who this might be right for
Primary Hypertension, Grade 2
Universitas Padjadjaran 60
Testing effectiveness (Phase 2)Study completedNCT01310036
What this trial is testing

Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 208
Testing effectiveness (Phase 2)Study completedNCT00117299
What this trial is testing

PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib

Who this might be right for
Sarcoma
University of Helsinki 45
Not applicableUnknownNCT01627119
What this trial is testing

The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric Cancer

Who this might be right for
Gastric Cancer
National Taiwan University Hospital 120
Early research (Phase 1)Study completedNCT04818632
What this trial is testing

AZD9833 China PK Study

Who this might be right for
ER+, HER2-, Metastatic Breast Cancer
AstraZeneca 28
Not applicableStudy completedNCT07086196
What this trial is testing

Real-World Outcomes of Ribociclib in First-Line Treatment for Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Metastatic HR+/HER2- Breast Cancer
Novartis Pharmaceuticals 350
Early research (Phase 1)Active Not RecruitingNCT05870579
What this trial is testing

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 28
Not applicableStudy completedNCT02321046
What this trial is testing

An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 26
Next Page